HNRNPA2B1: a novel target in pulmonary arterial hypertension
Purpose of ReviewPulmonary arterial hypertension (PAH) is a progressive clinical syndrome characterized by pulmonary vascular remodeling and elevated pulmonary artery pressure, associated with high morbidity and mortality. While targeted therapies have improved patient prognosis, restoring normal he...
Saved in:
Main Authors: | Yingying Wei, Daiqin Wu, Na Deng, Fujia Xu, Sihan Luo, Xinxin Fan, Haijun Guo, Jingjing Chen, Wei Li, Xiaoyun Si |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1497938/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Side-by-Side Comparison of Culture Media Uncovers Phenotypic and Functional Differences in Primary Mouse Aortic Mural Cells
by: Iman Ghasemi, et al.
Published: (2025-06-01) -
Endothelial Features Along the Pulmonary Vascular Tree in Chronic Thromboembolic Pulmonary Hypertension: Distinctive or Shared Facets?
by: Janne Verhaegen, et al.
Published: (2025-04-01) -
Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis
by: Lingna Zhao, et al.
Published: (2025-06-01) -
Growth and characterization of a tissue-engineered construct from human coronary artery smooth muscle cells
by: A. A. Sulgin, et al.
Published: (2020-07-01) -
Therapeutic potential of the annexin A family in atherosclerosis
by: Suha Jarad, et al.
Published: (2025-06-01)